Compare Sempra Energy (SRE) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sempra Energy vs 10X Genomics Inc — how do they compare? Sempra Energy trades at $84.9 (market cap $55.89B), while 10X Genomics Inc trades at $67.8 (market cap $8.55B). The key difference: Sempra Energy is far larger — about 6.5× 10X Genomics Inc's market cap, and Sempra Energy pays a 3.08% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SRE | TXG | |
|---|---|---|
Market Cap | $55.89B | $8.55B |
Sector | Utilities | Health |
52-Week High | $99.75 | $67.29 |
52-Week Low | $81.70 | $11.34 |
Enterprise Value | $92.52B | $8.08B |
Dividend Yield | 3.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TXG trades at $65.60, up 4.71% today, with strong technical momentum showing bullish moving averages and key support at $63. Fundamentally, the company demonstrates improving trends with Q2 2026 earnings beating estimates and revenue growth guidance raised, though profitability remains negative with a -12.18% net margin. Recent patent victory against Parse Biosciences strengthens competitive positioning.
The outlook remains cautiously optimistic with analyst consensus at 45% buy ratings and $50.78 price target. Key opportunities include Atera platform adoption and consumables growth, while risks center on valuation premiums and ongoing profitability challenges. The stock trades near resistance at $67 with institutional interest showing mixed signals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
